1. Home
  2. RGTIW vs IOVA Comparison

RGTIW vs IOVA Comparison

Compare RGTIW & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGTIW
  • IOVA
  • Stock Information
  • Founded
  • RGTIW 2013
  • IOVA 2007
  • Country
  • RGTIW United States
  • IOVA United States
  • Employees
  • RGTIW 140
  • IOVA N/A
  • Industry
  • RGTIW Retail: Computer Software & Peripheral Equipment
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RGTIW Technology
  • IOVA Health Care
  • Exchange
  • RGTIW Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • RGTIW N/A
  • IOVA 975.1M
  • IPO Year
  • RGTIW N/A
  • IOVA N/A
  • Fundamental
  • Price
  • RGTIW $10.66
  • IOVA $2.22
  • Analyst Decision
  • RGTIW
  • IOVA Buy
  • Analyst Count
  • RGTIW 0
  • IOVA 11
  • Target Price
  • RGTIW N/A
  • IOVA $11.90
  • AVG Volume (30 Days)
  • RGTIW 850.8K
  • IOVA 9.5M
  • Earning Date
  • RGTIW 03-11-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • RGTIW N/A
  • IOVA N/A
  • EPS Growth
  • RGTIW N/A
  • IOVA N/A
  • EPS
  • RGTIW N/A
  • IOVA N/A
  • Revenue
  • RGTIW $11,892,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • RGTIW N/A
  • IOVA $67.40
  • Revenue Next Year
  • RGTIW N/A
  • IOVA $56.32
  • P/E Ratio
  • RGTIW N/A
  • IOVA N/A
  • Revenue Growth
  • RGTIW N/A
  • IOVA 636.99
  • 52 Week Low
  • RGTIW $4.28
  • IOVA $1.64
  • 52 Week High
  • RGTIW $4.75
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • RGTIW N/A
  • IOVA 43.75
  • Support Level
  • RGTIW N/A
  • IOVA $2.27
  • Resistance Level
  • RGTIW N/A
  • IOVA $2.38
  • Average True Range (ATR)
  • RGTIW 0.00
  • IOVA 0.14
  • MACD
  • RGTIW 0.00
  • IOVA -0.01
  • Stochastic Oscillator
  • RGTIW 0.00
  • IOVA 28.21

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: